Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Murali

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
The Science of the Total Environment|December 13, 2021
Fate, bioaccumulation and toxicity of engineered nanomaterials in plants: Current challenges and future prospectsM Murali, H G Gowtham, S Brijesh Singh, et al.
The Science of the Total Environment|July 1, 2026
Retraction notice to "Fate, bioaccumulation and toxicity of engineered nanomaterials in plants: Current challenges and future prospects" [Sci. Total Environ. 811 (2022) 152249]M Murali, H G Gowtham, S Brijesh Singh, et al.
Bioinformatics (Oxford, England)|September 29, 2017
GraphSpace: stimulating interdisciplinary collaborations in network biologyAditya Bharadwaj, Divit P Singh, Anna Ritz, et al.
Saudi Journal of Biological Sciences|July 28, 2020
Biofabrication of zinc oxide nanoparticles from <i>Melia azedarach</i> and its potential in controlling soybean seed-borne phytopathogenic fungiT R Lakshmeesha, M Murali, Mohammad Azam Ansari, et al.
Ebiomedicine|September 6, 2023
Predictive models of long COVIDBlessy Antony, Hannah Blau, Elena Casiraghi, et al.
Scientific Reports|October 28, 2020
Defining the structural basis for human leukocyte antigen reactivity in clinical transplantationYue Gu, Robynne W K Koh, May Ling Lai, et al.
Plos One|June 18, 2024
Exploration of Type III effector Xanthomonas outer protein Q (XopQ) inhibitor from Picrasma quassioides as an antibacterial agent using chemoinformatics analysisPrasanna D Revanasiddappa, H G Gowtham, Chikkanna G S, et al.
Nature Communications|February 23, 2019
Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-A*11:01Yue Gu, Yee Hwa Wong, Chong Wai Liew, et al.
Scientific Reports|December 9, 2023
Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2Yue Gu, Bhuvaneshwari Shunmuganathan, Xinlei Qian, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2022
Generalizable Long COVID Subtypes: Findings from the NIH N3C and RECOVER ProgramsJustin T Reese, Hannah Blau, Timothy Bergquist, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
The Science of the Total Environment|December 13, 2021
Fate, bioaccumulation and toxicity of engineered nanomaterials in plants: Current challenges and future prospectsM Murali, H G Gowtham, S Brijesh Singh, et al.
The Science of the Total Environment|July 1, 2026
Retraction notice to "Fate, bioaccumulation and toxicity of engineered nanomaterials in plants: Current challenges and future prospects" [Sci. Total Environ. 811 (2022) 152249]M Murali, H G Gowtham, S Brijesh Singh, et al.
Bioinformatics (Oxford, England)|September 29, 2017
GraphSpace: stimulating interdisciplinary collaborations in network biologyAditya Bharadwaj, Divit P Singh, Anna Ritz, et al.
Saudi Journal of Biological Sciences|July 28, 2020
Biofabrication of zinc oxide nanoparticles from <i>Melia azedarach</i> and its potential in controlling soybean seed-borne phytopathogenic fungiT R Lakshmeesha, M Murali, Mohammad Azam Ansari, et al.
Ebiomedicine|September 6, 2023
Predictive models of long COVIDBlessy Antony, Hannah Blau, Elena Casiraghi, et al.
Scientific Reports|October 28, 2020
Defining the structural basis for human leukocyte antigen reactivity in clinical transplantationYue Gu, Robynne W K Koh, May Ling Lai, et al.
Plos One|June 18, 2024
Exploration of Type III effector Xanthomonas outer protein Q (XopQ) inhibitor from Picrasma quassioides as an antibacterial agent using chemoinformatics analysisPrasanna D Revanasiddappa, H G Gowtham, Chikkanna G S, et al.
Nature Communications|February 23, 2019
Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-A*11:01Yue Gu, Yee Hwa Wong, Chong Wai Liew, et al.
Scientific Reports|December 9, 2023
Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2Yue Gu, Bhuvaneshwari Shunmuganathan, Xinlei Qian, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2022
Generalizable Long COVID Subtypes: Findings from the NIH N3C and RECOVER ProgramsJustin T Reese, Hannah Blau, Timothy Bergquist, et al.
Pageof 15